Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2020 | RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding | CI |
2020 | RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding | CI |
Financials (USD)
Sales 2017 | 0.11 | Sales 2018 | 1.26 | Capitalization | 58.71M |
---|---|---|---|---|---|
Net income 2017 | -3M | Net income 2018 | -30M | EV / Sales 2017 * | - |
Net cash position 2017 | 3.15M | Net Debt 2018 | 12.9M | EV / Sales 2018 | 56,975,119 x |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-1.55
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 89.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
1st Jan change | Capi. | |
---|---|---|
0.00% | 182 | |
+6.95% | 7.41B | |
-32.64% | 3.24B | |
+6.59% | 2.66B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.21% | 606M | |
-8.30% | 539M |
- Stock Market
- Equities
- RVVQF Stock